Dynamical trajectory of glucocorticoids tapering and discontinuation in patients with rheumatoid arthritis commencing glucocorticoids with csDMARDs: a real-world data from 2009 to 2020.
Wen-Hui XieHong HuangGuangtao LiYanjie HaoYanni GuiYu WangXuerong DengJuan ZhaoYan GengLanLan JiXiaohui ZhangZhibo SongZhuoli ZhangPublished in: Annals of the rheumatic diseases (2021)
In patients with RA commencing GC besides csDMARDs, GC is feasibly discontinued with favourable control of disease activity in real-life setting, mostly without short-term flare. But the withdrawal time is far from reaching the recommended time frame, indicating the gap between real-world practice and current guidelines.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- juvenile idiopathic arthritis
- gas chromatography
- healthcare
- primary care
- electronic health record
- clinical practice
- big data
- quality improvement
- density functional theory
- mass spectrometry
- data analysis
- simultaneous determination
- high resolution
- tandem mass spectrometry